Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer

CompletedOBSERVATIONAL
Enrollment

1,920

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Metastatic Castration-resistant Prostates Cancer
Trial Locations (30)

0

Research Site, Seongnam-si

Research Site, Gangnam-gu

Research Site, Jongno-gu

Research Site, Seocho-gu

Research Site, Seodaemun-gu

Research Site, Turkey

Research Site, Alain

Research Site, Dubai

10408

Research Site, Goyang-si

11517

Research Site, Cairo

11522

Research Site, Cairo

11525

Research Site, Riyadh

11564

Research Site, Riyadh

11796

Research Site, Cairo

11835

Research Site, Cairo

15036

Research Site, Lima

21500

Research Site, Alexandria

23701

Research Site, Luxor

110005

Research Site, New Delhi

110029

Research Site, New Delhi

110085

Research Site, New Delhi

121001

Research Site, Faridabad

190011

Research Site, Srinagar

200005

Research Site, Valledupar

380015

Research Site, Ahmedabad

400012

Research Site, Mumbai

500003

Research Site, Secundrabad

560027

Research Site, Bengaluru

711103

Research Site, Howrah

751007

Research Site, Bhubaneshwar

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY